Literature DB >> 8744491

Brief report: psychopharmacology of autism spectrum disorders.

M H Lewis1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8744491     DOI: 10.1007/bf02172018

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


× No keyword cloud information.
  9 in total

1.  Fluoxetine treatment of children and adults with autistic disorder and mental retardation.

Authors:  E H Cook; R Rowlett; C Jaselskis; B L Leventhal
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1992-07       Impact factor: 8.829

2.  Clomipramine in autism: preliminary evidence of efficacy.

Authors:  C J McDougle; L H Price; F R Volkmar; W K Goodman; D Ward-O'Brien; J Nielsen; J Bregman; D J Cohen
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1992-07       Impact factor: 8.829

3.  A comparison of haloperidol and behavior therapy and their interaction in autistic children.

Authors:  M Campbell; L T Anderson; M Meier; I L Cohen; A M Small; C Samit; E J Sachar
Journal:  J Am Acad Child Psychiatry       Date:  1978

4.  Endogenous opioids and opiate antagonists in autism: brief review of empirical findings and implications for clinicians.

Authors:  C Gillberg
Journal:  Dev Med Child Neurol       Date:  1995-03       Impact factor: 5.449

Review 5.  Review of fenfluramine in the treatment of the developmental disabilities.

Authors:  M G Aman; R A Kern
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1989-07       Impact factor: 8.829

Review 6.  A novel biochemical model linking dysfunctions in brain melatonin, proopiomelanocortin peptides, and serotonin in autism.

Authors:  R S Chamberlain; B H Herman
Journal:  Biol Psychiatry       Date:  1990-11-01       Impact factor: 13.382

7.  Differential response of seven subjects with autistic disorder to clomipramine and desipramine.

Authors:  C T Gordon; J L Rapoport; S D Hamburger; R C State; G B Mannheim
Journal:  Am J Psychiatry       Date:  1992-03       Impact factor: 18.112

8.  Clomipramine treatment for stereotype and related repetitive movement disorders associated with mental retardation.

Authors:  M H Lewis; J W Bodfish; S B Powell; R N Golden
Journal:  Am J Ment Retard       Date:  1995-11

9.  Naltrexone in autistic children: behavioral symptoms and attentional learning.

Authors:  M Campbell; L T Anderson; A M Small; P Adams; N M Gonzalez; M Ernst
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1993-11       Impact factor: 8.829

  9 in total
  3 in total

1.  Pharmacologic treatment of repetitive behaviors in autism spectrum disorders: evidence of publication bias.

Authors:  Melisa Carrasco; Fred R Volkmar; Michael H Bloch
Journal:  Pediatrics       Date:  2012-04-23       Impact factor: 7.124

Review 2.  Autism: an emerging public health problem.

Authors:  Craig J Newschaffer; Laura Kresch Curran
Journal:  Public Health Rep       Date:  2003 Sep-Oct       Impact factor: 2.792

Review 3.  Prognosis in autism: do specialist treatments affect long-term outcome?

Authors:  P Howlin
Journal:  Eur Child Adolesc Psychiatry       Date:  1997-06       Impact factor: 4.785

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.